Chemotargets SL launches the CLARITY® v3.0 release

Chemotargets SL launches the CLARITY® v3.0 release - Main Image

Updates on data and models, and a new analytics module to navigate FAERS data

This new version includes as improvements to previous release.

  • Updates of data and models processed:

DATA - An expertly curated training set of 2.6 million compounds derived from patents, journals and public databases to ensure comprehensive coverage of the chemical space.

MODELS - Pharmacology (3,601 targets) and Toxicology (7 Preclinical and 520 Clinical endpoints).

This module provides users with access to standardized contents of FAERS and analytics, including identification of emergent and consolidated signals, while being able to link them to drugs-targets-safety-metabolites-diseases.

  • An Indications tab in the Drug Explorer module.

  • Option to customized Pharmacology or Toxicology profiling, with a one-click custom panel creation by target family (e.g., kinases or nuclear receptors) or toxicology category (e.g., all endpoints related to CardioTox).

  • Higher GUI navigation speed and better global performance.

 

Request a demonstration at clarity@chemotargets.com